- Resource Center
- Videos
- Videos
- Expert voices
- October 25, 2026
Why digital pathology is the future of hematology diagnosis
Dr. Pedro Martín Cabrera, consultant hematologist in hematopathology in Cambridge, UK, on image quality, AI, and what automation frees experts to do.
About Dr. Martín Cabrera
Dr. Martín Cabrera is a consultant in hematology and hemotherapy with about 15 years of experience in hemato-oncology diagnosis. He works in the hematopathology diagnostic service at a hospital in Cambridge, UK, and speaks regularly on the benefits of AI and digital pathology in hematology.
In his words
"No creo que tengamos ninguna duda de que la patología digital será el futuro."
I don't think there's any doubt that digital pathology will be the future.
"Las imágenes que se obtienen por escaneo con las plataformas actuales son equiparables a las del microscopio."
The images we get from today's scanning platforms are comparable to what we see through the microscope.
"Nos va a permitir liberar mucho más tiempo para poder desarrollar profesionalmente a esos profesionales."
It will free up much more time to develop our people professionally.
Why it matters
More marrows to review and fewer trained experts mean labs need to work more efficiently without losing quality. Full-Field™ imaging with AI decision support for peripheral blood smears and bone marrow aspirates helps labs keep up, and gives residents, technicians, and scientists a new way to train. See the clinical impact labs are reporting.
More expert voices
Scopio Labs' Full-Field Peripheral Blood Smear application is CE marked and FDA-cleared, and it's commercially available across the U.S., UK and Europe and other territories.
Scopio's Full-Field Bone Marrow Aspirate Application is CE-marked and cleared for sale in CE countries as well as in additional regions. Pending FDA clearance in the US.